Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.

Mar 17, 2025 - 15:18
 0
Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic
Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.